Stockreport

Organogenesis Achieves Primary Endpoint in Randomized Controlled Trial of PuraPly®AM

Organogenesis Holdings Inc. - Class A  (ORGO) 
Last organogenesis holdings inc. - class a earnings: 3/9 04:05 pm Check Earnings Report
PDF Statistically significant (pRCT compared PuraPly®AM plus standard of care to standard of care aloneResults strengthen existing clinical evidence supporting future covera [Read more]